期刊文献+

阿托伐他汀对高血压病患者脉压及血压昼夜节律的影响 被引量:2

Effect of Atorvastatin on Pulse Pressure and Blood Pressure Circadian Rhythm in Hypertensive Patients
下载PDF
导出
摘要 目的:探讨他汀类调脂药阿托伐他汀对高血压患者脉压及血压昼夜节律的影响。方法:选取40例高血压患者(服用降压药后血压控制均达标),监测其服用阿托伐他汀8周前后的24 h动态血压,比较服药前后脉压和血压昼夜节律的变化。结果:治疗后脉压减小,与治疗前比较差异有统计学意义(P<0.05);治疗后杓形节律增多,非杓形节律减少,与治疗前比较有统计学意义(P<0.01)。结论:阿托伐他汀可以降低血压控制达标的高血压患者的脉压,一定程度上恢复其血压昼夜节律,从而更有效的控制血压。 Objective:To study the effect of atorvastatin on pulse pressure and blood pressure circadian rhythm in hypertensive patients. Methods:Monitor 24-hour ambulatory blood pressure of 40 patients with hypertention before and after taking together with atorvastatin;compare pulse pressure and blood pressure circadian rhythm before and after the treatment. Results:Significant changes occur before and after the treatment in pulse pressure and blood pressure circadian rhythm,in addition to the decrease of pulse pressure and the increase patients with spatula-shaped rhythm. Conclusions:Atorvastatin can reduce blood pressure in hypertensive patients with standard blood pressure control,to some extent restore their blood pressure circadian rhythm,in order to more effectively control blood pressure.
作者 郭志昌
出处 《航空航天医学杂志》 2011年第2期135-136,共2页 Journal of Aerospace medicine
关键词 阿托伐他汀 高血压病 脉压 血压昼夜节律 Atorvastatin hypertension Pulse pressure Blood pressure circadian rhythm
  • 相关文献

参考文献3

二级参考文献30

  • 1张文斌,宋筱筱,傅国胜,蔡思宇.他汀类药物临床研究进展[J].心血管病学进展,2006,27(1):79-82. 被引量:40
  • 2周滔,周胜华,祁述善,沈向前,曾高峰,周宏年.阿托伐他汀对单核细胞髓过氧化物酶和过氧化物增殖活化剂受体γ表达的影响[J].临床心血管病杂志,2007,23(1):59-61. 被引量:4
  • 3张维忠,中华心血管病杂志,1994年,22卷,37页
  • 4Ikeda Y,Yong LH,Lefer AM.Rosuvastatin,a new HMGCoA reductase inhibitor,protects ischemic reperfused myocardium in normocholesterolemic rats[J].J Cardiovasc Pharmacol,2003,41:649-656.
  • 5Bell RM,Yellon DM.Atorvastatin,administered at the onset of reperfusion,and independent of lipid lowering,protects the myocardium by upregulating a prosurvival pathway[J].J Am Coll Cardiol,2003,41:508-515.
  • 6Yamakuchi M,Greer JJ,Cameron SJ.HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size[J].Circ Res,2005,96:1185-1192.
  • 7Brennan ML,Pennms MS,Van Lente F,et al.Prognostic value of myeloperoxidase in patients with chest pain[J].N Engl J Med,2003,349:1595-1604.
  • 8Rogler G,Lackner KJ,Schmitz G.Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro[J].Am J Cardiol,1995,76:114A-116A.
  • 9Park YS,Guijarro C,Kim Y,et al.Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats[J].Am J Kidney Dis,1998,31:190-194.
  • 10Yoshida M,Sawada T,Ishii H,et al.HMG-CoA reductase inhibitor modulatesmonocyte-endothelial cell interaction under physiological flow conditions invitro:involvement of Rho GTPase-dependent mechanism[J].ArteriosclerThromb Vasc Biol,2001,21:1165-1171.

共引文献38

同被引文献21

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部